For the next common core signaling pathway, the receptor ERBB2, which was mutated in breast cancer, received microenvironment factor CCL28 to activate TF BRCA1 through signaling transduction proteins CDC42 and ARRDC3 in TNBC and non-TNBC. This evidence concerns the gene ARRDC3 and breast cancer.